南昌治疗失眠的科南昌植物神经紊乱的治疗,南昌治强迫症的治疗费用,南昌心理医院电话多少,南昌市治幻想的医院哪家好,南昌焦虑症需要治疗吗,南昌治幻觉去哪家,南昌在专科治强迫症多少钱

(KGTV) -- The internet is exploding with people trying to help firefighters and animals in Australia amid raging wildfires - enter the koala challenge. The challenge, which was started by beverage company FITAID, encourages people to take a video of themselves latching onto the underside of a workout bench. An employee for the company tells 10News that, through Friday, it’ll donate for every video of the challenge posted on social media and tagged “#fitaid” and “koalachallenge.” RELATED: San Diego Zoo Global supports koala recovery amid devastating Australia wildfires“You don’t have to successfully complete it,” joked FITAID employee Jordan Costa. The company also plans to donate five percent of all sales from FITAID ZERO directly to those fighting the fires. Videos posted on social media show people successfully, and some not so successfully completing the challenge - all in the name of a good cause. 926

(KGTV) -- The nationwide search for the next superstar kicked off last August - bringing back American Idol dreams of fans who had to say goodbye to the reality show in 2016. It's the show that launched the careers of Kelly Clarkson, Carried Underwood and Jordin Sparks. And now it's back, right here on ABC. The Idol Bus traveled from Portland, Oregon, to Orlando, Florida, in its pursuit for talent, covering 23 cities across the country. Auditioning was made easier than ever as hopefuls also had the opportunity to submit audition videos online, as well as via select social media platforms using an official tag, #TheNextIdol, cultivating over 300,000 posts. Also, for the first time in “American Idol” history, hopefuls had the opportunity to audition through a livestream platform. The judges: Lionel Richie Katy PerryLuke BryanEmmy? Award-winning host and producer Ryan Seacrest will return as host of the beloved series.  Mark it on your calendars and set your DVR! American Idol returns to airwaves on SUNDAY, MARCH 11 at 8 p .m., on its new home on The ABC Television Network.    1168

.@GoyaFoods has been a staple of so many Latino households for generations.Now their CEO, Bob Unanue, is praising a president who villainizes and maliciously attacks Latinos for political gain. Americans should think twice before buying their products. #Goyaway https://t.co/lZDQlK6TcU— Julián Castro (@JulianCastro) July 9, 2020 337

(KGTV) — Three of the country's biggest ticket sellers told Congressional members they would support a mandate to include all ticket fees up front for consumers, ESPN reports.The current industry standard is to reveal those "all-in" fees to consumers only after they input their personal information, including name, address, and email address, ESPN says. The practice has been called anti-consumer and deceptive by Congressional members.Amy Howe, Ticketmaster's chief operating officer, told the House Committee on Energy and Commerce that the total ticket price "should be disclosed from the outset, not at the end of the purchase process."Representatives from Stubhub and AXS also said the companies would support "all-in" pricing. Stubhub's general counsel Stephanie Burns told the committee that the company tried the pricing strategy in 2014 and 2015, but moved away from it because consumers found it confusing when competitors' prices appeared lower in search engines online.Committee chairman Frank Pallone, D-N.J., said he was particularly concerned about higher fees sneaking up on consumers."Millions of Americans shop on the internet for tickets," Pallone said. "In some ways, the internet has made this experience more convenient, but it has also led to consumers being ripped off as they try to navigate a ticketing industry that for too long has operated in the dark."Representatives from the three companies also touched on deceptive websites and venues holding back tickets to increase scarcity. The companies, however, argued over the ease for consumers to digitally transfer tickets regardless of the original site used to purchase tickets.Currently, a bill in Congress known as the Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act is trying to push for new standards in the ticketing industry. 1853

(KGTV) -- Many scientists and doctors are cautiously optimistic about taking a step forward in the fight against COVID-19 after encouraging news from Pfizer Monday.Pfizer announced that early data revealed its vaccine was more than 90 percent effective in protecting trial participants against the coronavirus.The U.S. Federal Food and Drug Admiration still needs to review the drug for safety and efficacy, and Pfizer plans to seek an Emergency Use Authorization this month, but regardless some see this as a good sign for other vaccine trials.“I think this is frankly the break we’ve all been waiting for, and I hope we have many others to follow,” said Dr. Susan Little, a UC San Diego Professor of Medicine.UCSD is participating in Phase 3 clinical trials for Moderna, AstraZeneca, and Janssen vaccines.Little leads the AstraZeneca and Janssen trials, which resumed locally last week.“I think what this means for all of the trials that are available at this stage, this is incredibly good news,” she said. “So far, they all use the same approach to vaccine development; they are all targeting the same protein, the spike protein, on the coronavirus.”She expects similar results to come from Moderna’s early data sometime this year.“The Pfizer and the Moderna both use the same vaccine platform, the same structure for their vaccine construct, so there’s every reason to be very optimistic the Moderna study might show similar results,” she said. “While the AstraZeneca and the Janssen use a different vaccine construct, they both are targeting the same protein.”If Pfizer’s vaccine is approved, it could be given to healthcare workers and high-risk populations in just months, and the general population in 2021, according to Pfizer.Pfizer said it expects to produce 50 million vaccine doses globally in 2020 and up to 1.3 billion in 2021.Pfizer’s CEO, Albert Bourla, said he expects the vaccine to be free of charge for Americans. 1943